HemoBioTech, Inc.
Overview
HemoBioTech, Inc. is a biotechnology company focused on developing Hemoglobin Based Oxygen Carriers for use as a blood substitute. Its primary aim is to address blood supply shortages and eliminate risks associated with blood transfusions. The company's pioneering work could revolutionize the medical field by providing a safe and effective alternative to human blood.
Therapeutic areas
Blood SubstituteCardiovascular
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to HemoBioTech, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.